Reference
|
Treatment
|
Male
|
Female
|
| Berrebi
et al., 1988; &
|
NH
|
3.544+/-0.106
|
3.202+/-0.106
|
| Denenberg
et al., 1989
|
H
|
3.722+/-0.125
|
3.098+/-0.125
|
| Fitch
et al., 1990a
|
H
|
3.568+/-0.062
|
3.257+/-0.063
|
| H+Gdx(1)
|
3.506+/-0.079
|
||
| H+TP(4)
|
3.474+/-0.070
| ||
| H+DES(4)
|
3.380+/-0.118
| ||
| H+TX(4)
|
3.778+/-0.126
|
3.627+/-0.117
| |
| Fitch
et al., 1991b
|
H
|
3.377+/-0.067
|
3.123+/-0.053
|
| "H+TP(8,
12, 16)"
|
3.189+/-0.049
| ||
| "H+Ovx(8,
12, 16)"
|
3.342+/-0.065
| ||
| Fitch,
1990
|
V(E17-21)
+ ShamGdx(1) + H + Oil(4)
|
3.253+/-0.060
|
2.857+/-0.043
|
| FLT(E17-21)+Gdx(1)
+H+Oil(4)
|
2.971+/-0.094
|
||
| Fitch
et al., 1991a
|
"NH,
V(E17-P2), ShamGdx(3)
|
3.603+/-0.108
|
3.120+/-0.121
|
| NH,
FLT(E17-P2), Gdx (3)
|
3.272+/-0.084
|
||
| Denenberg
et al., 1991b
|
NH
|
3.630+/-0.134
|
3.301+/-0.067
|
| Experiment
1
|
NH+Gdx
(2)
|
3.376+/-0.062
|
|
| NH+TP(4)
|
3.362+/-0.126
| ||
| Experiment
2
|
NH
|
3.544+/-0.093
|
3.298+/-0.070
|
| NH+/-Gdx(2)
|
3.686+/-0.082
|
||
| NH+TP(4)
|
3.228+/-0.073
| ||
| H
|
3.626+/-0.098
|
3.282+/-0.067
| |
| H+Gdx(2)
|
3.627+/-0.089
|
||
| H+TP(4)
|
3.484+/-0.070
| ||
| Mack
et al., 1992
|
NH
|
3.800+/-0.117
|
3.468+/-0.066
|
| NH+Ovx(12)
|
3.721+/-0.117
| ||
| H
|
3.652+/-0.071
|
3.385+/-0.053
| |
| H+Ovx(12)
|
3.509+/-0.039
| ||
| Mack
et al., 1993
|
H
|
3.274+/-0.062
|
2.934+/-0.078
|
| H+Ovx(12)
|
3.190+/-0.074
| ||
| H+Ovx(12)+Es(25)
|
2.733+/-0.072
| ||
| Mack
et al., 1996b
|
NH
CS (E22)
|
3.014+/-.118
|
2.828+/-.114
|
| NH
CS (E22)+Gdx(E22)
|
3.084+/-.102
|
NH = nonhandled; H = handled; Gdx = male castration; Ovx = ovariectomy; DES = diethylstilbestrol; TX = tamoxifen; V = vehicle; FLT = flutamide; Es = estrogen; CS = Caesarian section; E = embryonic day; P = postnatal day (E and P used for clarification in all others, the number in parentheses refers to postnatal day of treatment)